Prostaglandin E1 Analogue
Pregnancy: X — teratogenic (Möbius syndrome risk in first trimester misuse)
Misoprostol
Brand names: Cytotec
Adult dose
Dose: PPH prevention: 600 mcg SL or PR at delivery. Cervical ripening: 25 mcg vaginally every 3–6h. Medical TOP: 800 mcg vaginally or SL after mifepristone 200mg 24–48h prior
Route: Sublingual, vaginal, or oral
Frequency: Per indication
PPH treatment: 800–1000 mcg PR/SL (WHO protocol). Miscarriage management: 800 mcg vaginally, repeat if needed.
Clinical pearls
- Thermostable — unlike oxytocin, does not require refrigeration (crucial in resource-limited settings)
- SL route: fastest onset but highest fever/shivering rate
- WHO: misoprostol 600mcg SL is recommended for PPH prevention when oxytocin unavailable
- Medical abortion: combined mifepristone + misoprostol is >95% effective at <10 weeks
Contraindications
- Previous uterine scar with cervical ripening regimens
- Active PID
- Unexplained vaginal bleeding (cervical ripening)
Side effects
- GI upset
- Diarrhoea
- Fever and chills (especially SL — common)
- Uterine hyperstimulation
- Headache
Interactions
- Oxytocin — additive uterotonic (space by 6h if both used)
- Antacids (Mg-containing) — increased misoprostol levels
Monitoring
- Uterine contractions (cervical ripening)
- Fetal heart rate
- Temperature and vital signs
- Blood loss (PPH)
Reference: WHO PPH Prevention Guidelines; RCOG Medical Management of Miscarriage. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21